91 results
8-K
EX-99.1
VRDN
Viridian Therapeutics Inc
8 May 24
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
7:09am
of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.
Viridian is advancing multiple
8-K
EX-99.1
x1b5ej
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
EX-99.1
zeaw44ns7 69qksj5p
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
EX-99.1
kzharu9765j72afn
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
EX-99.1
vlufdh 0ujk
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
0av4sm5x1kfbixfj cf
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
dl12 t4z30wqjfpdrszu
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
7a3dg5q3 j19ocvt
10 Jul 23
Regulation FD Disclosure
5:13pm
8-K
EX-10.1
1dn1yq3c
16 Jun 23
Departure of Directors or Certain Officers
4:31pm